Joint pain, skin changes, extreme fatigue – and often no clear diagnosis for years: collagen diseases can present in a wide variety of ways and place a significant burden on those affected. In these rare inflammatory...
A recent study from Hannover provides important insights into the understanding and future treatment of chronic hepatitis B. Researchers from the Hannover Medical School (MHH), the Helmholtz Centre for Infection...
In March 2026, the Europe-wide doctoral program “UNLIMITED – Understanding Lipid Immunometabolism to Treat Disease” was launched under the leadership of the University Medical Center Mainz. In cooperation with the...
Helmholtz researchers have created the first detailed protein map of specific sensory neurons that trigger pain. The team from the Max Delbrück Center and the Helmholtz Centre for Infection Research (HZI) determined the...
The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the emphasis has been on its underlying mechanisms and nucleases. In contrast, little research has...
Antimicrobial resistance is one of the greatest challenges to global health. Using an innovative high-throughput method, researchers from the Department “Epidemiology and Ecology of Antimicrobial Resistance” led by...
Even after the COVID-19 pandemic, infectious diseases remain among the greatest challenges to global health. At the same time, advances in biomedical research, data-driven methods, and clinical innovation are opening up...
Dr. Lina Herhaus has been awarded the Otto Meyerhof Award of the German Society for Biochemistry and Molecular Biology (GBM e.V.) at the 77th Mosbacher Kolloquium of the GBM. The prize, endowed with €5,000 and funded by...
Just in time for today’s World Tuberculosis Day, the new S3 guideline on tuberculosis prevention among newly arrived migrants has gone online at the Association of Scientific Medical Societies (AWMF). Commissioned by...
